Gender Male
Henry Chen is the Co-Founder and Board Member at Tulavi Therapeutics. Henry is the Managing Partner and co-Founder of Delos Capital. Mr. Chen also sits on the boards of Imperative Care, BaroNova, Atia Vision, Tanvex BioPharma, Allecra Therapeutics and Syndax Pharmaceuticals. Prior to establishing Delos in 2014, Mr. Chen was a Partner and Co-Head
of Asia at Permira, a European private equity firm with global reach and a total committed capital of approximately €20bn.
